Have a personal or library account? Click to login
Immunotherapy-Induced Acute Hepatitis in the Elderly: The Case of a Patient with Urothelial Carcinoma and a Review of the Literature Cover

Immunotherapy-Induced Acute Hepatitis in the Elderly: The Case of a Patient with Urothelial Carcinoma and a Review of the Literature

Forum of Clinical Oncology
Volume 12 (2021): Issue 3 (December 2021)
By: Ioannou Alexandros,  Papaxoinis Georgios,  Dimitroulopoulos Dimitrios,  Tryfonopoulos Dimitrios and  Gouveris Panagiotis  
Open Access
|Feb 2022

Authors

Ioannou Alexandros

alexandros.ioannou@studio.unibo.it

Gastroenterology Department, Agios Savvas Cancer Hospital, Athens, Greece

Papaxoinis Georgios

2nd Department of Medical Oncology, Agios Savvas Cancer Hospital

Dimitroulopoulos Dimitrios

Gastroenterology Department, Agios Savvas Cancer Hospital, Athens, Greece

Tryfonopoulos Dimitrios

2nd Department of Medical Oncology, Agios Savvas Cancer Hospital

Gouveris Panagiotis

2nd Department of Medical Oncology, Agios Savvas Cancer Hospital
DOI: https://doi.org/10.2478/fco-2021-0003 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Page range: 28 - 33
Submitted on: Apr 11, 2021
|
Accepted on: Jul 15, 2021
|
Published on: Feb 1, 2022
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Immunotherapy-related adverse events,
pembrolizumab,
immunotherapy-related hepatitis,
elderly
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2022 Ioannou Alexandros, Papaxoinis Georgios, Dimitroulopoulos Dimitrios, Tryfonopoulos Dimitrios, Gouveris Panagiotis, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 12 (2021): Issue 3 (December 2021)Next article